Current literature supports the findings in the present study that low expression of cytoplasmic CYP2S1 and of nuclear CYP2W1 results in shorter survival of breast cancer patients, a trend which was maintained even in multivariate analysis. Here, CYP2S1 is linked to breast carcinoma.